Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital

Journal of Medical Microbiology

Volumn 58, Issue 4, 2009, Pages 430-435

  Karthika, R Uma ^a   Rao, R Srinivasa ^a   Sahoo, Suchismita ^a   Shashikala, P ^b   Kanungo, Reba ^b   Jayachandran, S ^a   Prashanth, K ^a  

^a PONDICHERRY UNIVERSITY   (India)

^b PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL DNA; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; INDIA; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SPECTROPHOTOMETRY; TERTIARY HEALTH CARE; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; GENOTYPE; HUMANS; INDIA; PHENOTYPE; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 65649119360     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.002105-0     Document Type: Article

References (38)

1. Chandra, R., Kapil, A., Sharma, P. & Das, B. (2002). Identification of Acinetobacter species isolated from clinical specimens by amplified ribosomal DNA restriction analysis. Indian J Med Res 116, 1-4.
2. CLSI (2006). Performance Standards for Antimicrobial Susceptibility Testing; 16th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
3. D'Agata, E. M., Gerrits, M. M., Tang, Y. W., Samore, M. & Kusters, J. G. (2001). Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 22, 550-554. (Pubitemid 33104881)
4. Da Silva, G. J., Correia, M., Vital, C., Ribeiro, G., Sousa, J. C., Leitao, R., Peixe, L. & Duarte, A. (2002). Molecular characterization of blaIMP-5, a new integron-borne metallo-b-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett 215, 33-39. (Pubitemid 35232579)
5. Edwards, R., Hawkyard, C. V. & Hashmi, P. S. (1998). Biological assay for the detection of metallo-beta-lactamases in Bacteroides fragilis. Br J Biomed Sci 55, 169-171. (Pubitemid 28479668)
6. Gallego, L. & Towner, K. J. (2000). Carriage of class I integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii. In Acinetobacter 2000, 5th International Symposium on the Biology of Acinetobacter, abstract 15. Noordwijkerhout, The Netherlands.
7. Gerner-Smidt, P., Tjenberg, I. & Ursing, J. (1991). Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 29, 277-282.
8. Gupta, V., Datta, P. & Chander, J. (2006). Prevalence of metallo-β-lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect 52, 311-314. (Pubitemid 46137438)
9. Hirakata, Y., Izumikawa, K., Yamaguchui, T., Takemura, H., Tanaka, H., Yoshida, R., Matsuda, J., Nakano, M., Tomono, K. & other authors (1998). Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-beta lactamase gene blaIMP. Antimicrob Agents Chemother 42, 2006-2011. (Pubitemid 28363084)
10. Jeong, S. H., Kwon Bae, I., Park, K. O., An, Y. J., Sohn, S. G., Jang, S. J., Sung, K. H., Yang, K. S., Lee, K. & other authors (2006). Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol 44, 423-431.
11. Jesudason, M. V., Kandathil, A. J. & Balaji, V. (2005). Comparison of two methods to detect carbapenemase and metallo-beta-lactamase production in clinical isolates. Indian J Med Res 121, 780-783. (Pubitemid 41025315)
12. Jones, R. N., Biedenbach, D. J., Sader, H. S., Fritsche, T. R., Toleman, M. A. & Walsh, T. R. (2005). Emerging epidemic of metallo-β-lactamase mediated resistances. Diagn Microbiol Infect Dis 51, 77-84. (Pubitemid 40215415)
13. Joshi, S. G., Litake, G. M., Ghole, V. S. & Niphadkar, K. B. (2003a). Plasmid borne extended spectrum beta-lactamase in a clinical isolate of Acinetobacter baumannii. J Med Microbiol 52, 1125-1127. (Pubitemid 38648158)
14. Joshi, S. G., Litake, G. M., Niphadkar, K. B. & Ghole, V. S. (2003b). Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 9, 187-190. (Pubitemid 36834378)
15. Kenchappa, P. & Sreenivasmurthy, B. (2003). Simplified panel of assimilation tests for identification of Acinetobacter species. Indian J Pathol Microbiol 46, 700-706. (Pubitemid 39186261)
16. VIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43, 1584-1590.
17. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49, 4485-4491.
18. Lee, J. H., Choi, C. H., Kang, H. Y., Lee, J. Y., Kim, J., Lee, Y. C., Seol, S. Y., Cho, D. T., Kim, K. W., Song, D. Y. & Lee, J. C. (2007). Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 59, 633-639. (Pubitemid 47073395)
19. Liu, P. Y. & Wu, W. L. (1997). Use of different PCR-based DNA fingerprinting techniques and pulsed-field gel electrophoresis to investigate the epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Diagn Microbiol Infect Dis 29, 19-28. (Pubitemid 27472916)
20. Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H. & Quale, J. (2000). Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, inter-institutional spread, and relation to antibiotic usage. Clin Infect Dis 31, 101-106. (Pubitemid 32268946)
21. Mendiratta, D. K., Deotale, V. & Narang, P. (2005). Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area. Indian J Med Res 121, 701-703. (Pubitemid 40846827)
22. Navon-Venezia, S., Ben-Ami, R. & Carmeli, Y. (2005). Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18, 306-313. (Pubitemid 41017634)
23. IMP-4 among gram negative pathogens in a clinical setting in Australia. Clin Infect Dis 41, 1549-1556.
24. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J. D. & Nordmann, P. (2000). Characterization of VIM-2, a carbapenemhydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44, 891-897. (Pubitemid 30165266)
25. Prashanth, K. & Badrinath, S. (2000). Simplified phenotypic tests for identification of Acinetobacter spp. and their antimicrobial susceptibility status. J Med Microbiol 49, 773-778. (Pubitemid 30666627)
26. Prashanth, K. & Badrinath, S. (2004). In vitro susceptibility pattern of Acinetobacter species to commonly used cephalosporins, quinolones and aminoglycosides. Indian J Med Microbiol 22, 97-103.
27. Prashanth, K. & Badrinath, S. (2005). Epidemiological investigation of nosocomial Acinetobacter infections using AP-PCR and pulse field gel electrophoresis. Indian J Med Res 122, 408-418. (Pubitemid 43264271)
28. Prashanth, K. & Badrinath, S. (2006). Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Indian J Med Microbiol 24, 39-44.
29. Sarkar, B., Biswas, D., Prasad, R. & Sharma, J. P. (2006). A clinicomicrobiological study on the importance of Pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta-lactamase production. Indian J Pathol Microbiol 49, 44-48.
30. Seward, R. J. (1999). Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin Microbiol Infect 5, 308-318.
31. Sinha, M. & Srinivasa, H. (2007). Mechanisms of resistance to carbapenems in meropenem resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol 25, 121-125.
32. Sinha, M., Srinivasa, H. & Macaden, R. (2007). Antibiotic resistance profile and extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 126, 63-67. (Pubitemid 350020550)
33. Taneja, N., Maharwal, S. & Sharma, M. (2003). Imipenem resistance in nonfermenters causing nosocomial urinary tract infections. Indian J Med Sci 57, 294-299. (Pubitemid 39663738)
34. Vila, J., Marcos, M. A. & Jimenez de Anta, M. T. (1996). A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol 44, 482-489.
35. Walsh, T. R., Toleman, M. A., Poirel, L. & Nordmann, P. (2005). Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18, 306-325.
36. Yano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T. & Inoue, M. (2001). Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 45, 1343-1348. (Pubitemid 32374100)
37. Yong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M. & Chong, Y. (2002). Imipenem-EDTA disk method for differentiation of metallo-β-lactamase producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40, 3798-3801.
38. Yum, J. H., Yi, K., Lee, H., Yong, D., Lee, K., Kim, J. M., Rossolini, G. M. & Chong, Y. (2002). Molecular characterization of metallo-β- lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two novel integrons carrying blaVIM-2 gene cassettes. J Antimicrob Chemother 49, 837-840. (Pubitemid 34537647)